SCA1 molecular genetics: A history of a 13 year collaboration against glutamines

Human Molecular Genetics

Volumn 10, Issue 20, 2001, Pages 2307-2311

  Orr, Harry T ^a   Zoghbi, Huda Y ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GLUTAMINE; GUANINE; MUTANT PROTEIN; POLYGLUTAMINE; TRINUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; GENE MUTATION; GENETIC CODE; GENETIC STABILITY; HUMAN; MOLECULAR CLONING; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN INTERACTION; PURKINJE CELL; REVIEW; SPINOCEREBELLAR DEGENERATION; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT;

ANIMALIA; ATAXIA; MUS MUSCULUS;

EID: 0035475788     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.20.2307     Document Type: Review

References (40)

1. Glutamine repeats and neurodegeneration
2. Uber degenerative Atrophie der spinalen Hinterstrange
3. Uber Ataxie mit besonderer Berucksichtigung der hereditaren Formen
4. Sur l'heredoataxia cerebelleuse
5. Hereditary ataxia and HLA
6. Spinocerebellar ataxia: Localization of an autosomal dominant locus between two markers on human chromosome 6
7. Localization of the autosomal dominant HLA-linked spinocerebellar ataxia (SCA1) locus, in two kindreds, with an 8-cM subregion of chromosome 6p
8. The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps telomeric to the HLA complex and is closely linked to the D6S89 locus in three kindreds
9. The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps centromeric to D6S89 and shows no recombination in nine large kindreds with a dinucleotide repeat at the AM10 locus
10. Hereditary ataxia: Clinical study through six generations
11. Spinocerebellar ataxia: Variable age of onset and linkage to human leukocyte antigen in a large kindred
12. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
13. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
14. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
15. Unstable DNA region and phenotypic variation in myotonic dystrophy
16. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene
17. An unstable triplet repeat in a gene related to myotonic muscular dystrophy
18. Unstable DNA sequence in myotonic dystrophy
19. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
20. Evidence for a mechanism predisposing to intergenerational CAG instability in spinocerebellar ataxia type 1
21. Identification and characterization of the gene causing type 1 spinocerebellar ataxia
22. A novel CAG repeat configuration in the SCA1 gene: Implications for the molecular diagnosis of spinocerebellar ataxia type 1
23. Molecular and clinical correlations in spinocerebellar ataxia type 1 (SCA1): Evidence for familial effects on the age of onset
24. Cryptic and polar variation of the Fragile X repeat could result in predisposing normal alleles
25. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat
26. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
27. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
28. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations
29. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
30. Mutation of the E6-Ap ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
31. Genetic suppression of polyglutamine toxicity in Drosophila
32. Mechanisms of chaperone suppression of polyglutamine disease: Selectivity, synergy and modulation of protein solubility in Drosophila
33. Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils
34. Overexpression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice
35. Polyglutamine expansion in ataxin-1 downregulates specific neuronal genes prior to any known pathogenic changes in spinocerebellar ataxia type 1
36. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract
37. Identification of a self-association region within the SCA1 gene product, ataxin-1
38. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1
39. Identification and characterization of an ataxin-1 interacting protein: A1Up a ubiquitin-like nuclear protein